Portfolio comparison
Immatics Biotechnologies vs Luxtera
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Immatics Biotechnologies
Patents indexed
7
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapyoncologygene_editing
Top Patents7 enriched
US 11407807· 2022
Using Specific Immune Cells to Fight Cancers Like Lung and Breast Cancer
US 10377797· 2019
Training Immune Cells to Fight Cancer Using Specific Markers
US 10314897· 2019
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
Activity by Decade
2010s3
2020s4
Company B
Luxtera
Patents indexed
1
Year range
2021
Most recent
2021
telecommunicationssemiconductorsconsumer_electronicsai_ml
Top Patents1 enriched
US 11137544· 2021
How Tiny Bumps in Light Paths Improve Chip Communication
Activity by Decade
2020s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.